Yes DB Shawn has had the early call on an increase
in expenses. He calls some Patient Payment Programs
and Promotional expenses. Therefore a Cash burn of
$30m plus for the half year and extra overall costs
to increase market share. I believe this is why the
reality check after initial hype to SP.
- Forums
- ASX - By Stock
- What MYX chart shouts
MYX
mayne pharma group limited
Add to My Watchlist
1.34%
!
$5.29

Yes DB Shawn has had the early call on an increase in expenses....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.29 |
Change
0.070(1.34%) |
Mkt cap ! $428.9M |
Open | High | Low | Value | Volume |
$5.29 | $5.33 | $5.15 | $502.4K | 95.13K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 211 | $5.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.30 | 390 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 31124 | 5.280 |
3 | 433 | 5.270 |
3 | 1722 | 5.260 |
4 | 7736 | 5.250 |
3 | 1477 | 5.240 |
Price($) | Vol. | No. |
---|---|---|
5.290 | 705 | 11 |
5.300 | 945 | 5 |
5.310 | 1271 | 11 |
5.320 | 863 | 4 |
5.330 | 6452 | 4 |
Last trade - 15.29pm 18/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online